Healthcare AI startup Heidi Health has raised $65 million in Series B funding led by billionaire Steve Cohen’s Point72, marking one of the largest rounds in the medical scribe space this year. The funding comes as the company claims to have saved doctors more than 18 million hours across 70 million patient visits in just 18 months since launch.
The latest investment underscores how AI is transforming healthcare administration. Heidi Health, founded by trauma surgeon Dr. Thomas Kelly, is on a mission to automate the most repetitive and time-consuming tasks in healthcare.
Dr. Kelly’s vision is clear: doctors are overwhelmed by administrative work, and AI can step in to help. “We wanted to build an AI care partner that would stand alongside clinicians and take care of the admin so that individual providers, like me, can feel empowered to deliver the care that we dedicated our lives to,” Kelly said.
Since launching in early 2024, the company reports rapid growth, claiming to have returned ‘18 million hours to frontline healthcare providers from more than 70 million patient visits in 116 countries.’ Such strong traction caught the attention of Cohen’s Point72, which saw exceptional adoption and engagement metrics.
“They had seen all the scribes before,” Dr. Kelly explained. “They’d never seen product adoption and usage metrics like they’d seen in Heidi. They also loved that we were obsessed about the end-user experience, because they saw most of our competitors were just doing top-down sales.”
The funding arrives at a critical time, as physician burnout continues to rise globally. Administrative work consumes nearly 40% of doctors’ time, and Heidi Health’s AI medical scribe helps reduce this burden by transcribing notes, generating summaries, and managing follow-up tasks.
However, Heidi Health goes beyond transcription. The company follows a model-agnostic strategy, developing its own AI while integrating systems like Google’s Gemini to maximize performance. “This model-agnostic approach means that we can optimize our accuracy, latency, and cost,” Kelly noted.
The round also brings seasoned leaders into the company. Dr. Simon Kos, Microsoft’s former Chief Medical Officer, joins the team along with Paul Williamson, Plaid’s Head of Revenue. Their combined expertise in enterprise software and healthcare will accelerate Heidi Health’s growth and innovation.
Competition in the medical AI space is intensifying, with DeepScribe, Ambiance Healthcare, and Abridge among the major players. Yet Heidi Health’s freemium model and strong user focus appear to be paying off, with the company now engaging over 2 million clinicians each week.
What differentiates this round is Heidi’s global ambition. While many AI healthcare startups focus on developed markets, Dr. Kelly envisions a world where Heidi expands access to care everywhere. “Imagine a world where any healthcare provider in the world can use Heidi to increase their clinical capacity, where they can practice in a war zone, or a refugee camp, or a region hit by climate change,” he said.
Adding to its innovation streak, Heidi Health recently launched an AI agent that automatically calls patients on behalf of doctors, further automating complex administrative workflows.
With a total of $96.6 million raised to date from investors including Goodwater Capital, Headline, Blackbird VC, and LG Technology Ventures, the company plans to use its new capital to advance product development and expand AI capabilities.
Heidi Health’s rapid rise signals that AI in healthcare has evolved from experimental to essential. Backed by Point72 and driven by explosive adoption, the company is positioning itself as a core infrastructure player in medical automation—a fast-growing space transforming how healthcare systems operate.
